Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development
Display Omitted
Gespeichert in:
| Autor*in: |
Al-Ghorbani, Mohammed [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS - Vidoni, Eric D. ELSEVIER, 2019, an international journal, San Diego, Calif |
|---|---|
| Übergeordnetes Werk: |
volume:65 ; year:2016 ; pages:110-117 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.bioorg.2016.02.006 |
|---|
| Katalog-ID: |
ELV013580922 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV013580922 | ||
| 003 | DE-627 | ||
| 005 | 20230623105944.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bioorg.2016.02.006 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016001000008.pica |
| 035 | |a (DE-627)ELV013580922 | ||
| 035 | |a (ELSEVIER)S0045-2068(16)30014-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 540 | |
| 082 | 0 | 4 | |a 540 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.68 |2 bkl | ||
| 100 | 1 | |a Al-Ghorbani, Mohammed |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| 264 | 1 | |c 2016 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Antiproliferative |2 Elsevier | |
| 650 | 7 | |a Angiogenesis |2 Elsevier | |
| 650 | 7 | |a DLA cells |2 Elsevier | |
| 650 | 7 | |a Piperazine–benzothiazole |2 Elsevier | |
| 700 | 1 | |a Pavankumar, G.S. |4 oth | |
| 700 | 1 | |a Naveen, P. |4 oth | |
| 700 | 1 | |a Thirusangu, Prabhu |4 oth | |
| 700 | 1 | |a Prabhakar, B.T. |4 oth | |
| 700 | 1 | |a Khanum, Shaukath Ara |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Vidoni, Eric D. ELSEVIER |t TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |d 2019 |d an international journal |g San Diego, Calif |w (DE-627)ELV003009882 |
| 773 | 1 | 8 | |g volume:65 |g year:2016 |g pages:110-117 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bioorg.2016.02.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.68 |j Gerontologie |j Geriatrie |q VZ |
| 951 | |a AR | ||
| 952 | |d 65 |j 2016 |h 110-117 |g 8 | ||
| 953 | |2 045F |a 540 | ||
| author_variant |
m a g mag |
|---|---|
| matchkey_str |
alghorbanimohammedpavankumargsnaveenpthi:2016----:yteiadnniltcoefoepprznbnohaoenlgeonoaclrztoahetmr |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.68 |
| publishDate |
2016 |
| allfields |
10.1016/j.bioorg.2016.02.006 doi GBVA2016001000008.pica (DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 44.68 bkl Al-Ghorbani, Mohammed verfasserin aut Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier Pavankumar, G.S. oth Naveen, P. oth Thirusangu, Prabhu oth Prabhakar, B.T. oth Khanum, Shaukath Ara oth Enthalten in Elsevier Vidoni, Eric D. ELSEVIER TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS 2019 an international journal San Diego, Calif (DE-627)ELV003009882 volume:65 year:2016 pages:110-117 extent:8 https://doi.org/10.1016/j.bioorg.2016.02.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.68 Gerontologie Geriatrie VZ AR 65 2016 110-117 8 045F 540 |
| spelling |
10.1016/j.bioorg.2016.02.006 doi GBVA2016001000008.pica (DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 44.68 bkl Al-Ghorbani, Mohammed verfasserin aut Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier Pavankumar, G.S. oth Naveen, P. oth Thirusangu, Prabhu oth Prabhakar, B.T. oth Khanum, Shaukath Ara oth Enthalten in Elsevier Vidoni, Eric D. ELSEVIER TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS 2019 an international journal San Diego, Calif (DE-627)ELV003009882 volume:65 year:2016 pages:110-117 extent:8 https://doi.org/10.1016/j.bioorg.2016.02.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.68 Gerontologie Geriatrie VZ AR 65 2016 110-117 8 045F 540 |
| allfields_unstemmed |
10.1016/j.bioorg.2016.02.006 doi GBVA2016001000008.pica (DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 44.68 bkl Al-Ghorbani, Mohammed verfasserin aut Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier Pavankumar, G.S. oth Naveen, P. oth Thirusangu, Prabhu oth Prabhakar, B.T. oth Khanum, Shaukath Ara oth Enthalten in Elsevier Vidoni, Eric D. ELSEVIER TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS 2019 an international journal San Diego, Calif (DE-627)ELV003009882 volume:65 year:2016 pages:110-117 extent:8 https://doi.org/10.1016/j.bioorg.2016.02.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.68 Gerontologie Geriatrie VZ AR 65 2016 110-117 8 045F 540 |
| allfieldsGer |
10.1016/j.bioorg.2016.02.006 doi GBVA2016001000008.pica (DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 44.68 bkl Al-Ghorbani, Mohammed verfasserin aut Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier Pavankumar, G.S. oth Naveen, P. oth Thirusangu, Prabhu oth Prabhakar, B.T. oth Khanum, Shaukath Ara oth Enthalten in Elsevier Vidoni, Eric D. ELSEVIER TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS 2019 an international journal San Diego, Calif (DE-627)ELV003009882 volume:65 year:2016 pages:110-117 extent:8 https://doi.org/10.1016/j.bioorg.2016.02.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.68 Gerontologie Geriatrie VZ AR 65 2016 110-117 8 045F 540 |
| allfieldsSound |
10.1016/j.bioorg.2016.02.006 doi GBVA2016001000008.pica (DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 44.68 bkl Al-Ghorbani, Mohammed verfasserin aut Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development 2016 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier Pavankumar, G.S. oth Naveen, P. oth Thirusangu, Prabhu oth Prabhakar, B.T. oth Khanum, Shaukath Ara oth Enthalten in Elsevier Vidoni, Eric D. ELSEVIER TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS 2019 an international journal San Diego, Calif (DE-627)ELV003009882 volume:65 year:2016 pages:110-117 extent:8 https://doi.org/10.1016/j.bioorg.2016.02.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.68 Gerontologie Geriatrie VZ AR 65 2016 110-117 8 045F 540 |
| language |
English |
| source |
Enthalten in TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS San Diego, Calif volume:65 year:2016 pages:110-117 extent:8 |
| sourceStr |
Enthalten in TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS San Diego, Calif volume:65 year:2016 pages:110-117 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Gerontologie Geriatrie |
| institution |
findex.gbv.de |
| topic_facet |
Antiproliferative Angiogenesis DLA cells Piperazine–benzothiazole |
| dewey-raw |
540 |
| isfreeaccess_bool |
false |
| container_title |
TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |
| authorswithroles_txt_mv |
Al-Ghorbani, Mohammed @@aut@@ Pavankumar, G.S. @@oth@@ Naveen, P. @@oth@@ Thirusangu, Prabhu @@oth@@ Prabhakar, B.T. @@oth@@ Khanum, Shaukath Ara @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV003009882 |
| dewey-sort |
3540 |
| id |
ELV013580922 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV013580922</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623105944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bioorg.2016.02.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016001000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV013580922</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0045-2068(16)30014-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.68</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Al-Ghorbani, Mohammed</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antiproliferative</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiogenesis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DLA cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Piperazine–benzothiazole</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pavankumar, G.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naveen, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thirusangu, Prabhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prabhakar, B.T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khanum, Shaukath Ara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vidoni, Eric D. ELSEVIER</subfield><subfield code="t">TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS</subfield><subfield code="d">2019</subfield><subfield code="d">an international journal</subfield><subfield code="g">San Diego, Calif</subfield><subfield code="w">(DE-627)ELV003009882</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:110-117</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bioorg.2016.02.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.68</subfield><subfield code="j">Gerontologie</subfield><subfield code="j">Geriatrie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">110-117</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
| author |
Al-Ghorbani, Mohammed |
| spellingShingle |
Al-Ghorbani, Mohammed ddc 540 ddc 610 bkl 44.68 Elsevier Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| authorStr |
Al-Ghorbani, Mohammed |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV003009882 |
| format |
electronic Article |
| dewey-ones |
540 - Chemistry & allied sciences 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
540 540 DE-600 610 VZ 44.68 bkl Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole Elsevier |
| topic |
ddc 540 ddc 610 bkl 44.68 Elsevier Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole |
| topic_unstemmed |
ddc 540 ddc 610 bkl 44.68 Elsevier Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole |
| topic_browse |
ddc 540 ddc 610 bkl 44.68 Elsevier Antiproliferative Elsevier Angiogenesis Elsevier DLA cells Elsevier Piperazine–benzothiazole |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
g p gp p n pn p t pt b p bp s a k sa sak |
| hierarchy_parent_title |
TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |
| hierarchy_parent_id |
ELV003009882 |
| dewey-tens |
540 - Chemistry 610 - Medicine & health |
| hierarchy_top_title |
TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV003009882 |
| title |
Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| ctrlnum |
(DE-627)ELV013580922 (ELSEVIER)S0045-2068(16)30014-1 |
| title_full |
Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| author_sort |
Al-Ghorbani, Mohammed |
| journal |
TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |
| journalStr |
TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
110 |
| author_browse |
Al-Ghorbani, Mohammed |
| container_volume |
65 |
| physical |
8 |
| class |
540 540 DE-600 610 VZ 44.68 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Al-Ghorbani, Mohammed |
| doi_str_mv |
10.1016/j.bioorg.2016.02.006 |
| dewey-full |
540 610 |
| title_sort |
synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| title_auth |
Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development |
| url |
https://doi.org/10.1016/j.bioorg.2016.02.006 |
| remote_bool |
true |
| author2 |
Pavankumar, G.S. Naveen, P. Thirusangu, Prabhu Prabhakar, B.T. Khanum, Shaukath Ara |
| author2Str |
Pavankumar, G.S. Naveen, P. Thirusangu, Prabhu Prabhakar, B.T. Khanum, Shaukath Ara |
| ppnlink |
ELV003009882 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.bioorg.2016.02.006 |
| up_date |
2024-07-06T19:16:00.359Z |
| _version_ |
1803858330632847360 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV013580922</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623105944.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bioorg.2016.02.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016001000008.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV013580922</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0045-2068(16)30014-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.68</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Al-Ghorbani, Mohammed</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Synthesis and an angiolytic role of novel piperazine–benzothiazole analogues on neovascularization, a chief tumoral parameter in neoplastic development</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antiproliferative</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiogenesis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DLA cells</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Piperazine–benzothiazole</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pavankumar, G.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Naveen, P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thirusangu, Prabhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Prabhakar, B.T.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Khanum, Shaukath Ara</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Vidoni, Eric D. ELSEVIER</subfield><subfield code="t">TRIAL OF OXALOACETATE IN ALZHEIMER’S DISEASE (TOAD): FINAL RESULTS</subfield><subfield code="d">2019</subfield><subfield code="d">an international journal</subfield><subfield code="g">San Diego, Calif</subfield><subfield code="w">(DE-627)ELV003009882</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:65</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:110-117</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bioorg.2016.02.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.68</subfield><subfield code="j">Gerontologie</subfield><subfield code="j">Geriatrie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">65</subfield><subfield code="j">2016</subfield><subfield code="h">110-117</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
| score |
7.402815 |